ABSTRACT:Introduction: TGF- is a multifunctional regulator of chondrocyte proliferation, differentiation, and extracellular matrix production. Dysregulation of TGF- action has been implicated in cartilage diseases such as osteoarthritis. TGF- signaling is transduced through a pair of transmembrane serine/threonine kinases, known as the type I (ALK5) and type II receptors. However, recent studies on endothelial cells have identified ALK1 as a second type I TGF- receptor and have shown that ALK1 and ALK5 have opposing functions in these cells. Here we examined ALK1 expression and its regulation of TGF- signaling and responses in human chondrocytes. Materials and Methods: ALK1 expression in human chondrocytes was examined by RT-PCR and Western blot. The ability of ALK1 to form complexes with other TGF- receptors was determined by affinity labeling/ immunoprecipitation and by immunoprecipitation followed by Western blot. The effect of ALK1 on TGF-1-induced signaling and responses was determined by varying ALK1 expression levels and measuring transcriptional activity using promoter/luciferase assays, Smad1/5 and Smad3 phosphorylation, and expression of type II collagen, PAI-1, and fibronectin. Results: Our results indicate that ALK1 is expressed in human chondrocytes and that it is a component of the TGF- receptor system, associating with ALK5, type II TGF- receptor, endoglin, and betaglycan. Furthermore, we show that both ALK1 and ALK5 are needed for TGF--induced phosphorylation of intracellular mediators Smad1/5, whereas only ALK5 is essential for TGF-1-induced phosphorylation of Smad3. In addition, our results show that ALK1 inhibits, whereas ALK5 potentiates, TGF--induced Smad3-driven transcriptional activity and the expression of PAI-1, fibronectin, and type II collagen in chondrocytes. Conclusions: Our results suggest that ALK1 and ALK5 display opposing functions in human chondrocytes, implicating an essential role for ALK1 in the regulation of TGF- signaling and function in these cells.